Cytek Biosciences, Inc. (CTKB) reported revenue at $57.5 million

Cytek Biosciences, Inc. (NASDAQ: CTKB) reported revenue for the quarter came in at $57.5 million versus the consensus estimate of $61.49 million.

For earnings history and earnings-related data on Cytek Biosciences, Inc. (CTKB) click here.

You May Also Be Interested In

• Goldman Sachs Adjust Monthly US Director's Cut List
• JPMorgan Downgrades Li Ning Co. Ltd. (2331:HK) (LNNGF) to Neutral
• Citi cuts SK Hynix price target to KRW3,000,000 on FX pressure